Images List Premium Download Classic

Congestive Heart Failure

Congestive Heart Failure-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Implantable neurostimulator-implemented method for managing tachyarrhythmic risk during sleep through vagus nerve stimulation
October 19, 2017 - N°20170296817

A patient suffering from congestive heart failure is at increased risk of cardiac arrhythmogenesis during sleep, particularly if experiencing central sleep apnea as a co-morbidity. Low intensity peripheral neurostimulation therapies that target imbalance of the autonomic nervous system have been shown to improve clinical outcomes. Thus, bi-directional autonomic regulation therapy is delivered to the cervical vagus nerve at an intensity ...
Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
October 19, 2017 - N°20170296506

The present application provides methods for treating cardiovascular conditions. The methods can include administering a transient receptor potential vanilloid 1 (trpv1) receptor agonist to an epidural space. The methods can be used to treat a variety of conditions such as hypertension, prehypertension, mild hypertension, severe hypertension, refractory hypertension, congestive heart failure and myocardial scarring.
Use of pimobendan for the reduction of heart size and/or the delay of onset ...
Boehringer Ingelheim Vetmedica Gmbh
October 12, 2017 - N°20170290829

The invention relates to pimobendan for use in a method of reducing the heart size and/or delaying the onset of clinical symptoms in a patient suffering from asymptomatic (occult, preclinical) heart failure, preferably congestive heart failure, due to mitral valve disease (mvd), and/or delaying the onset of heart failure, preferably congestive heart failure, in a patient suffering from ...
Congestive Heart Failure Patent Pack
Download + patent application PDFs
Congestive Heart Failure Patent Applications
Download + Congestive Heart Failure-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Congestive Heart Failure-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Chelator-targeting ligand conjugates for cardiovascular imaging
Cell>point, Llc
October 05, 2017 - N°20170281806

Disclosed are methods of imaging a site in a heart of a subject to detect cardiovascular disease that involve stressing a subject, administering to the stressed subject an effective amount of a radionuclide-labeled chelator-glucose analog conjugate, and imaging the heart of the subject by detecting a signal generated by the conjugate in the heart of the subject. Also disclosed are ...
Compounds, compositions and methods
Cytokinetics, Incorporated
September 21, 2017 - N°20170267638

Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
Intrinsic frequency hemodynamic waveform analysis
California Institute Of Technology
September 14, 2017 - N°20170258343

Hardware and software methodology are described for cardiac health measurement. Hemodynamic waveforms variously acquired for a subject are analyzed to calculate or approximate intrinsic frequencies in two domains in two domains across the dicrotic notch. The intrinsic frequencies provide metrics/ measures that correlate to the cardiac health of the subject. The systems may be used for monitoring a condition and/...
Congestive Heart Failure Patent Pack
Download + patent application PDFs
Congestive Heart Failure Patent Applications
Download + Congestive Heart Failure-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Congestive Heart Failure-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Sphinogosine-1-phosphate receptor modulators for treatment of cardiopulmonary disorders
The Scripps Research Institute
August 03, 2017 - N°20170217963

The invention provides compounds effective as sphingosine-1-phosphate receptor modulators for treatment of cardiopulmonary diseases, such as hypertension (including malignant hypertension), angina, myocardial infarction, cardiac arrhythmias, congestive heart failure, coronary heart disease, atherosclerosis, angina pectoris, dysrhythmias, cardiomyothopy (including hypertropic cardiomyothopy), heart failure, cardiac arrest, bronchitis, asthma, chronic obstructive pulmonary disease, cystic fibrosis, croup, emphysema, pleurisy, pulmonary fibrosis, pneumonia, pulmonary embolus, ...
Use of ribose for treatment of subjects having congestive heart failure
Ribocor, Inc.
August 03, 2017 - N°20170216330

A method for treating a human subject having congestive heart failure is disclosed herein. An exemplary method includes orally administering a 10 g to 50 g dose of d-ribose daily to a subject having congestive heart failure, wherein the d-ribose is administered in a single dose after fasting, and the administration of d-ribose is continued over a period of time effective to ...
Treatment of congestive heart failure with electrical stimulation, and associated systems and methods
Nevro Corp.
July 27, 2017 - N°20170209699

Systems and methods for treating congestive heart failure with high frequency stimulation are disclosed. A representative method for treating a patient includes applying an electrical signal having a frequency of from about 1 khz to about 100 khz to the patient via a treatment system that includes a signal delivery element in electrical communication with the patient's vagus nerve at a portion ...
Systemic delivery of virus vectors encoding urocortin-2 and related genes to treat diabetes-related cardiac dysfunctions ...
The Regents Of The University Of California
June 29, 2017 - N°20170182129

In alternative embodiments, provided are methods for treating, ameliorating or protecting (preventing) congestive heart failure (chf) or a diabetes-related cardiac dysfunction, comprising: providing a urocortin 2-encoding and/or a urocortin 3-encoding nucleic acid, transcript or message, or gene, operatively linked to a transcriptional regulatory sequence, optionally contained in an expression vehicle or a vector such as an adeno-associated virus (aav), ...
Pulmonary artery implant apparatus and methods of use thereof
The Regents Of The University Of California
June 22, 2017 - N°20170172771

The present invention relates to an implantable apparatus and methods of use thereof for treating congestive heart failure. An apparatus of this invention may be anchored by implantation of a section of the apparatus within in a branch pulmonary artery, for example the left pulmonary artery, which then positions and anchors another section, for example a device frame section of ...
Treating dysfunctional cardiac tissue
Bioventrix, Inc.
June 08, 2017 - N°20170156865

Medical devices, systems, and methods reduce the distance between two points in tissue, often for treatment of congestive heart failure and often in a minimally invasive manner. An anchor is inserted along an insertion path through a first wall of the heart. An arm of the anchor is deployed and rotationally positioned according to a desired alignment. Application of tension ...
Treatment of congestive heart failure and other cardiac dysfunction using a gdf15 modulator
Aveo Pharmaceuticals, Inc.
May 18, 2017 - N°20170137505

The invention provides methods and compositions of treating a subject having a cardiac-related disorder such as congestive or chronic heart failure (chf), cardiac hypertrophy, cardiac hypotrophy, and other cardiac myopathies/dystrophies. The methods comprise administering an effective amount of a composition that modulates, for example, reduces or inhibits, gdf 15 activity in the subject.
Congestive Heart Failure Patent Pack
Download + patent application PDFs
Congestive Heart Failure Patent Applications
Download + Congestive Heart Failure-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Congestive Heart Failure-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods for renal neuromodulation
Medtronic Ardian Luxembourg S.a.r.l.
March 23, 2017 - N°20170080230

Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e. G., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment ...
Method and apparatus for performing peritoneal ultrafiltration
Triomed Ab
March 16, 2017 - N°20170072125

Method and apparatus for ultrafiltration of a patient being overhydrated due to congestive heart failure, comprising a cassette having four inlets/outlets. A patient tube is connected to a patient connector, intended to be connected to a patient line for access to a peritoneal cavity of the patient. The patient tube comprises a flow pump for addition and removal of ...
Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
Janssen Pharmaceutica Nv
March 16, 2017 - N°20170071970

The present invention is directed to the use of co-therapy comprising administration of canagliflozin and phentermine for the treatment of obesity and obesity related disorders. More particularly, the present invention is directed to co-therapy for treating obesity, for promoting weight loss and/or for suppressing appetite; for treating, delaying, slowing the progression of and/or preventing metabolic disorders (including for ...
Methods and materials for treating elevated sympathetic nerve activity conditions
Mayo Foundation For Medical Education And Research
March 09, 2017 - N°20170065327

This document provides methods and materials involved in treating hypertension (e. G., age-associated hypertension, resistant hypertension, or chronic refractory hypertension), heart failure (e. G., congestive heart failure), or kidney disease (e. G., chronic kidney disease). For example, methods and materials involved in administering one or more sympatholytic agents to a patient to identify the patient as having an elevated baseline ...
Heteroaromatic compounds and their use as dopamine d1 ligands
Mayo Foundation For Medical Education And Research
March 02, 2017 - N°20170057947

And pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating d1-mediated (or d1-associated) disorders including, e. G., schizophrenia (e. G., its cognitive and negative symptoms), cognitive impairment (e. G., cognitive impairment associated with schizophrenia, ad, pd, or pharmacotherapy therapy), adhd, ...
Prodrug of an ice inhibitor
Mayo Foundation For Medical Education And Research
January 26, 2017 - N°20170022249

Compound i is useful for treating il-1 mediated diseases such as rheumatoid arthritis, inflammatory bowel disease, crohn's disease, ulcerative colitis, inflammatory peritonitis, septic shock, pancreatitis, traumatic brain injury, organ transplant rejection, osteoarthritis, asthma, psoriasis, alzheimer's disease, myocardial infarction, congestive heart failure, huntington's disease, atherosclerosis, atopic dermatitis, leukemias and related disorders, myelodysplastic syndrome, uveitis or multiple myeloma.
Platelet rich plasma formulations
Mayo Foundation For Medical Education And Research
January 26, 2017 - N°20170020923

Compositions for platelet rich plasma (prp) and neutrophil-depleted prp are provided. Methods for treating ischemia damaged tissues by delivering a prp composition, in some embodiments a neutrophil-depleted prp composition to the damaged tissue are provided. In some variations, the compositions may be useful to treat ischemic heart disease and repair damaged cardiovascular tissue following acute myocardial infarction including congestive heart ...
Adjuvant therapy to standard of care (soc) diuretic treatment
Madeleine Pharmaceuticals Pty Ltd
January 26, 2017 - N°20170020899

A therapeutic method for treating and/or preventing diseases and medical conditions typically treated by administering diuretic agents (eg congestive heart failure). The method may comprise, for example, administering to a subject a diuretic agent in combination with vessel dilator (vsdl) or a variant or modified peptide thereof. The administration of the diuretic agent may be a component of a ...
Loading